What is the ROE (Return on Equity) of Soligenix this year?
The ROE of Soligenix this year is -2.43 undefined.
Soligenix ROE 2024
Soligenix ROE
-2.43
Ticker
SNGX
ISIN
US8342233074
WKN
A2AS7Q
In 2024, Soligenix's return on equity (ROE) was -2.43, a -143.57% increase from the 5.59 ROE in the previous year.
Soligenix Aktienanalyse
What does Soligenix do?
Soligenix Inc. is a biopharmaceutical company specialized in the development of treatment and prevention methods for serious diseases. It was founded in 1987 and is headquartered in Princeton, New Jersey. The business model of Soligenix Inc. is based on the research and development of innovative therapies for diseases that are currently difficult to treat or have no known cure. The company's research and development focus on three core areas: vaccines, cancer therapies, and rare diseases. In the field of vaccines, Soligenix Inc. has focused on developing therapies against biological threats such as anthrax, smallpox, or botulinum toxin-like toxins. These threats are not only a potential danger to national security but can also occur in the form of natural disasters or terrorist attacks. Soligenix Inc. has several promising vaccine candidates in clinical trials, including an anthrax vaccine that works faster and safer than currently available vaccines. In the field of cancer therapy, the company focuses on developing new immunotherapies for the treatment of solid tumors. Soligenix Inc. uses a technology platform called "RiVax" based on the inactivation of botulinum toxin. This platform has already proven promising in redirecting the body's immune system to tumor cells and killing them. As the last core area, the company is dedicated to the treatment of rare diseases that are often overlooked and insufficiently treated. Soligenix Inc. has already developed a promising candidate for the treatment of oropharyngeal candidiasis (fungal infections in the mouth and throat) and is in phase III clinical trials. Overall, Soligenix Inc. has developed a range of promising products in various stages of clinical trials. In addition to the mentioned candidates, the company has also developed a promising treatment for relieving the side effects of cancer chemotherapy. This product called SGX942 is currently in phase III clinical trials. In addition to ongoing clinical studies, Soligenix Inc. has also established strong partnerships with government organizations such as the US National Institutes of Health or the Biomedical Advanced Research and Development Authority (BARDA). These partnerships are important to secure funding for ongoing research projects and allow the company to bring its products to market quickly. Soligenix Inc. has experienced strong growth in recent years and has established itself as a key player in the biopharmaceutical industry. The company has received several awards for its research work and innovation potential in the past and seems to be on a good path to bring further groundbreaking therapies to the market. Soligenix ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Soligenix's Return on Equity (ROE)
Soligenix's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Soligenix's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Soligenix's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Soligenix’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Soligenix stock
How has the Return on Equity (ROE) of Soligenix developed compared to the previous year?
The ROE of Soligenix has increased by -143.57% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Soligenix?
A high ROE indicates that Soligenix generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Soligenix?
A low ROE can indicate that Soligenix is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Soligenix affect the company?
A change in ROE (Return on Equity) of Soligenix can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Soligenix?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Soligenix?
Some factors that can influence Soligenix's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Soligenix pay?
Over the past 12 months, Soligenix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Soligenix is expected to pay a dividend of 0 USD.
What is the dividend yield of Soligenix?
The current dividend yield of Soligenix is .
When does Soligenix pay dividends?
Soligenix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Soligenix?
Soligenix paid dividends every year for the past 0 years.
What is the dividend of Soligenix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Soligenix located?
Soligenix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Soligenix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Soligenix from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Soligenix pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Soligenix in the year 2023?
In the year 2023, Soligenix distributed 0 USD as dividends.
In which currency does Soligenix pay out the dividend?
The dividends of Soligenix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Soligenix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Soligenix
Our stock analysis for Soligenix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Soligenix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
